Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Relmada Therapeutics, Inc. (RLMD)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
16.93-0.92 (-5.15%)
At close: 04:00PM EST
16.93 0.00 (0.00%)
After hours: 06:03PM EST
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 12/6/2021
Current
Market Cap (intraday)
N/A
Enterprise Value
N/A
Trailing P/E
N/A
Forward P/E
N/A
PEG Ratio (5 yr expected)
N/A
Price/Sales (ttm)
N/A
Price/Book (mrq)
N/A
Enterprise Value/Revenue
N/A
Enterprise Value/EBITDA
N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 0.09
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 340.00
52 Week Low 316.53
50-Day Moving Average 323.46
200-Day Moving Average 329.55

Share Statistics

Avg Vol (3 month) 391.19k
Avg Vol (10 day) 395.67k
Shares Outstanding 516.75M
Implied Shares Outstanding 6N/A
Float 814.24M
% Held by Insiders 12.21%
% Held by Institutions 157.28%
Shares Short (Nov 14, 2021) 4872.43k
Short Ratio (Nov 14, 2021) 413.69
Short % of Float (Nov 14, 2021) 45.11%
Short % of Shares Outstanding (Nov 14, 2021) 44.98%
Shares Short (prior month Oct 14, 2021) 4953.26k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Sep 29, 2019
Ex-Dividend Date 4N/A
Last Split Factor 21:4
Last Split Date 3Sep 29, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Sep 29, 2021

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-64.05%
Return on Equity (ttm)-115.07%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -110.94M
Net Income Avi to Common (ttm)-112.14M
Diluted EPS (ttm)-3.81
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)88.09M
Total Cash Per Share (mrq)5.03
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)4.98
Book Value Per Share (mrq)6.46

Cash Flow Statement

Operating Cash Flow (ttm)-61.14M
Levered Free Cash Flow (ttm)-19.39M
Advertisement
Advertisement